ChrisBintener's Avatar

ChrisBintener

@chrisbintener.bsky.social

Project Officer at Alzheimer Europe #Gerontologist communicating about #neurodegeneration #dementia & related topics. @IHI-PROMINENT.bsky.social @fluidx-ad.bsky.social

972 Followers  |  954 Following  |  36 Posts  |  Joined: 21.09.2023  |  2.0648

Latest posts by chrisbintener.bsky.social on Bluesky

Preview
Dementia Researcher: AAIC Day Four 2025 Highlights In this podcast we share a few selected highlights from the Alzheimer’s Association International Conference (AAIC) day two and day three of the main event in Toronto and Online, 27the - 31st Jul...

🎙️ Final episode of our #AAIC25 Podcasts! Highlights include sleep & dementia risk, blood-based biomarkers, and the rise of AI in research. Guests: Dr Shea Andrews, Dr Joe Butler, Dr Lindsey Sinclair & @hdemnitzking.bsky.social

pod.fo/e/306803

31.07.2025 03:20 — 👍 6    🔁 3    💬 0    📌 0
Post image

Our second #AAIC25 special is live! Dr James Brady with @stirlandia.bsky.social, @isabelscst.bsky.social & @felixwittmann.bsky.social. Video & audio streaming now.

pod.fo/e/304afe

29.07.2025 13:17 — 👍 11    🔁 5    💬 0    📌 0
Lifestyle Interventions to Improve Cognition in Later Life

Lifestyle Interventions to Improve Cognition in Later Life

Editorial from @jama.com: The US POINTER study suggests that modest lifestyle interventions can enhance cognitive health in aging populations, offering a practical and cost-effective approach to dementia prevention.

ja.ma/3IIrv0f

#AAIC2025

28.07.2025 18:25 — 👍 10    🔁 4    💬 1    📌 1
Preview
FluiDx-AD - A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of AD Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither…

🧠On #WorldBrainDay #WBD2025 we highlight FluiDx-AD, improving early Alzheimer’s diagnosis with saliva & blood-based tests.
Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement.
🎥 vimeo.com/1058971988
🔗 linktr.ee/FluiDx_AD

22.07.2025 09:48 — 👍 1    🔁 1    💬 0    📌 0
Preview
PROMINENT PROMINENT will create a digital platform for precision medicine to improve the diagnosis and treatment of neurodegenerative disease and co-morbidities. The overriding…

🧠Today on #WorldBrainDay #WBD2025, we highlight the @ihieurope.bsky.social funded @ihi-prominent.bsky.social project, creating a digital platform for precision medicine in Alzheimer’s disease.
vimeo.com/835447757

🔗 www.ihi-prominent.eu

22.07.2025 09:42 — 👍 3    🔁 3    💬 0    📌 0
 A promotional graphic from Alzheimer Europe inviting European residents aged 18 and over to take part in a public opinion poll on dementia research. The image is set on a blue background and includes the Alzheimer Europe logo in the top right corner. On the left side, there is a stylised mobile phone screen with a QR code and the text: “Scan here to participate!”. Below it reads: “Results will be published on the Alzheimer Europe website in October 2025.”

On the right side, a blue speech bubble contains key information about the poll:

    “We are inviting all European residents (aged 18+) to take part in our public opinion poll.”

    “No prior experience with dementia research needed”

    “Available in 12 languages”

    “Takes approximately 10 minutes to complete”

    “Your input will help shape future research and data sharing”

At the top left, a brain icon is followed by the heading: “Tell us what you think about dementia research!”

A promotional graphic from Alzheimer Europe inviting European residents aged 18 and over to take part in a public opinion poll on dementia research. The image is set on a blue background and includes the Alzheimer Europe logo in the top right corner. On the left side, there is a stylised mobile phone screen with a QR code and the text: “Scan here to participate!”. Below it reads: “Results will be published on the Alzheimer Europe website in October 2025.” On the right side, a blue speech bubble contains key information about the poll: “We are inviting all European residents (aged 18+) to take part in our public opinion poll.” “No prior experience with dementia research needed” “Available in 12 languages” “Takes approximately 10 minutes to complete” “Your input will help shape future research and data sharing” At the top left, a brain icon is followed by the heading: “Tell us what you think about dementia research!”

Alzheimer Europe’s public opinion poll about attitudes and perceptions on dementia research and data sharing is still open. Participate today to help shape the future of #dementia research! alzheimereurope.qualtrics.com/jfe/form/SV_...

14.07.2025 09:25 — 👍 0    🔁 1    💬 0    📌 0
Preview
Spotlight on early-career researchers, an interview with Xin Xia - Prominent In this first edition of our spotlight on early-career researchers interview series, we talked with Xin Xia who does her PhD at the Karolinska Institutet in Stockholm, Sweden. Can you […]

Want to know more?
Check out our spotlight on early career researchers interview with first author Xin Xia: www.ihi-prominent.eu/spotlight-on...

01.07.2025 14:16 — 👍 2    🔁 1    💬 0    📌 0
Preview
Diagnostic and prognostic multimodal prediction models in Alzheimer's disease: A scoping review - Xin Xia, Lukas A Duffner, Christophe Bintener, Angela Bradshaw, Daphné Lamirel, Linus Jönsson, 2025 Background Multimodal prediction models for Alzheimer's disease (AD) are emerging as promising tools for improving detection and informing prognosis. Obje...

What are the predictive objectives, constituting predictors and algorithms, as well as the performance of existing multimodal prediction models for Alzheimer's disease?

Have a read of our latest scoping review funded through @ihieurope.bsky.social: journals.sagepub.com/doi/10.1177/...

01.07.2025 14:15 — 👍 1    🔁 2    💬 1    📌 0
Preview
Younger generations less likely to have dementia, study suggests Researchers say people born more recently, particularly women, have lower risk at same age as their grandparents People born more recently are less likely to have dementia at any given age than earlier generations, research suggests, with the trend more pronounced in women. According to the World Health Organization, in 2021 there were 57 million people worldwide living with dementia, with women disproportionately affected. However, while dementia risk increases with age, experts have long stressed it is not an inevitability of getting older. Continue reading...

Younger generations less likely to have dementia, study suggests

02.06.2025 15:06 — 👍 95    🔁 12    💬 10    📌 4
Post image

The @ihieurope.bsky.social funded @ihi-prominent.bsky.social Newsletter #4 is out now.

Highlights 🌟EU authorises lecanemab for early Alzheimer’s, clinician survey on decision support, latest biomarker research & European Parliament debate.

Read & subscribe: mailchi.mp/266ae009900a...

05.06.2025 13:20 — 👍 1    🔁 2    💬 0    📌 0
"Was macht KI mit der Wissenschaftskommunikation?" mit Mike Schäfer
YouTube video by Wissenschaft im Dialog "Was macht KI mit der Wissenschaftskommunikation?" mit Mike Schäfer

Die Aufzeichnung unseres Lunchtalks mit @mss7676.bsky.social ist jetzt auf unserem YouTube-Kanal verfügbar. Im Gespräch ging es u.a. darum, wie #KI wissenschaftliches Arbeiten verändert, was das für die #Wisskomm bedeutet und welche Kompetenzen wichtig für AI literacy sind:
youtu.be/w2R0PmmAA9c

23.04.2025 13:44 — 👍 11    🔁 4    💬 0    📌 0
Preview
Responding to EMA’s decision on donanemab: How PROMINENT is advancing precision medicine in Alzheimer’s disease - Prominent On 28 March 2025, the Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion on the marketing authorisation application of Eli […]

🚨 EMA issued a negative opinion on donanemab. PROMINENT responds with AI-driven tools to identify risks, collect real-world data & support equitable access.

Thanks to Hanneke Rhodius-Meester (AmsterdamUMC & Oslo Univ. Hospital) for sharing her thoughts!

www.ihi-prominent.eu/responding-t...

28.03.2025 14:01 — 👍 3    🔁 2    💬 0    📌 0
Preview
European Commission authorises lecanemab for treatment of early Alzheimer’s disease On 15 April, the European Commission granted EU authorisation for lecanemab to treat mild cognitive impairment (MCI) in the early stages of Alzheimer’s disease, under strict con

The European Commission has authorised #lecanemab for treatment of early Alzheimer’s disease under strict conditions. Find out more: www.alzheimer-europe.org/news/europea...

16.04.2025 05:59 — 👍 3    🔁 1    💬 0    📌 0

Yup, that's very dangerous stuff - equally great in taste.

11.04.2025 12:07 — 👍 0    🔁 0    💬 0    📌 0
Preview
Alzheimer Europe urges European Commission to affirm the CHMP’s positive opinion on lecanemab Following recent developments regarding the marketing authorisation app

In a letter to Commissioner Olivér Várhelyi, Alzheimer Europe urges the European Commission to affirm the European Medicines Agency’s positive opinion on #lecanemab, enabling Europeans to access a first disease-modifying treatment for #Alzheimers disease.

www.alzheimer-europe.org/news/alzheim...

04.04.2025 07:44 — 👍 4    🔁 0    💬 0    📌 0
The European Commission refers lecanemab decision to Appeal Committee /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission (EC) has decided to refer the...

BioArctic AB's partner Eisai today announced that the European Commission (EC) has decided to refer the marketing authorisation approval decision of lecanemab in the EU to the Appeal Committee.
www.prnewswire.com/news-release...

01.04.2025 11:59 — 👍 1    🔁 0    💬 0    📌 0
Preview
Final Symposium - adis-project.eu Towards Earlier Diagnosis of Alzheimer’s Disease Date and Location: 25th and 26th of June 2025, Schloss Birlinghoven, Fraunhofer IZB Campus, Sankt Augustin https://www.scai.fraunhofer.de/en/contact-fr...

Are you interested in research towards an earlier diagnosis of Alzheimer's disease?
Don't miss this end of project event 25-26 June @ Schloss Birlinghoven, Sankt Augustin (Germany) with leading experts on neurodegeneration research.
Online attendance free of charge ↩️
adis-project.eu/final-sympos...

01.04.2025 07:35 — 👍 1    🔁 0    💬 0    📌 0

I'd say one gets used to it, but last minute changes remain stressful. Wishing you great success with your event!

28.03.2025 06:50 — 👍 1    🔁 0    💬 1    📌 0

All backoffice programme books look like this :)

27.03.2025 15:35 — 👍 0    🔁 0    💬 1    📌 0

🆕 Updated European Public Health Starter Pack with:

🔹 European Patients Forum @eupatientsforum.bsky.social

🔹 Cancer Patients Europe @cancerpatientseu.bsky.social

🔹 Tilly Metz MEP, Vice-Chair of the European Parliament Committee on Public Health (SANT) @tillymetz.bsky.social

go.bsky.app/K2JB6CN

25.03.2025 08:44 — 👍 8    🔁 2    💬 0    📌 0
Post image

The new Alzheimer Europe Dementia in Europe Magazine features an interview with our Scientific Coordinator Erik Christensen, putting a spotlight on the novel test trio to detect peptide biomarkers for enhanced diagnosis & management of #Alzheimer's disease ⤵️
www.alzheimer-europe.org/sites/defaul...

17.03.2025 08:37 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image Post image Post image

Closing the LETHE project webinar, Miriam Pannone shares her experience about being involved in an Advisory Board to improve dementia research. #PublicInvolvement #LETHEproject

14.03.2025 10:20 — 👍 0    🔁 0    💬 0    📌 0
Post image Post image Post image Post image

Now speaking at the LETHE project webinar, Jeroen Bruinsma Maastricht Uni discusses why changing behaviour to reduce dementia risk is challenging. #DementiaRiskReduction #PublicInvolvement #LETHEproject

14.03.2025 10:04 — 👍 0    🔁 0    💬 0    📌 0
Post image

Continuing the LETHE project webinar, Soraya Moradi Bachiller Alzheimer Europe shares her experience in involving the public in dementia risk disclosure. #PublicInvolvement #DementiaAwareness #LETHEproject

14.03.2025 09:53 — 👍 0    🔁 0    💬 0    📌 0
Post image Post image Post image Post image

Up next in the LETHE project webinar: Francesca Mangialasche from World-Wide FINGERS presents how Public Involvement enhances dementia risk reduction research. #PublicInvolvement #DementiaPrevention #LETHEproject

14.03.2025 09:50 — 👍 0    🔁 0    💬 0    📌 0
Post image

Kicking off the LETHE project webinar, Ana Diaz Ponce Alzheimer Europe outlines why Public Involvement matters & how it shapes dementia research. #PublicInvolvement #DementiaRiskReduction #LETHEproject

14.03.2025 09:35 — 👍 0    🔁 0    💬 0    📌 0
Preview
Special issue of journal highlights impacts of IMI and IHI projects on Alzheimer’s disease The papers in Frontiers in Neurology demonstrate how public-private collaborative research through IMI and now IHI is making a difference in the Alzheimer’s disease field.

🧠 In #BrainAwarenessWeek, take a deep dive into the impact of IMI and IHI projects on #Alzheimer's disease 👉 europa.eu/!MbFHv6
#IHITransformingHealth #HorizonEU #health #research #dementia

13.03.2025 10:21 — 👍 6    🔁 4    💬 0    📌 0
Preview
Research behind the scenes with Oriol Grau and Ferran Lugo: Barcelonaβeta Brain Research Center's involvement in the PROMINENT project - Prominent The PROMINENT project aims to improve the diagnosis and treatment of neurodegenerative diseases through precision medicine, amongst others, by leveraging the expertise at the Barcelonaβeta Brain Resea...

Advances in neuroimaging offer new avenues for earlier detection of Alzheimer’s disease.
Oriol Grau (Barcelonaβeta Brain Research Center) discusses his work in the @ihieurope.bsky.social funded @ihi-prominent.bsky.social project. #BrainAwarenessWeek 🔗 www.ihi-prominent.eu/research-beh...

11.03.2025 08:23 — 👍 1    🔁 2    💬 0    📌 0

Welcome to new followers! Please tag your suggestions for #Care leaders and innovators who should be included in this list! Don’t be shy about nominating yourselves too!! #CareInnovation #SocialCare #Gerontology #Geriatrics #Dementia #Disabilty #PublicHealth #PrimaryCare #MedTech

20.11.2024 11:37 — 👍 11    🔁 2    💬 2    📌 0

Thank you! It’s much appreciated.

10.03.2025 16:46 — 👍 0    🔁 0    💬 0    📌 0

@chrisbintener is following 20 prominent accounts